The atherogenic index of plasma and carotid atherosclerosis in a community population: a population-based cohort study in China
Background The atherogenic index of plasma (AIP) is an important alternative metabolic biomarker of atherosclerosis and cardiovascular diseases. Nevertheless, the correlation between the AIP and carotid atherosclerosis is unknown among the general population. Methods A total of 52,380 community resi...
Saved in:
| Published in | Cardiovascular diabetology Vol. 22; no. 1; pp. 125 - 13 |
|---|---|
| Main Authors | , , , , , , |
| Format | Journal Article |
| Language | English |
| Published |
London
BioMed Central
27.05.2023
BMC |
| Subjects | |
| Online Access | Get full text |
| ISSN | 1475-2840 1475-2840 |
| DOI | 10.1186/s12933-023-01839-y |
Cover
| Abstract | Background
The atherogenic index of plasma (AIP) is an important alternative metabolic biomarker of atherosclerosis and cardiovascular diseases. Nevertheless, the correlation between the AIP and carotid atherosclerosis is unknown among the general population.
Methods
A total of 52,380 community residents, aged ≥ 40 years who underwentcervical vascular ultrasound from December 2017 to December 2020 in Hunan China, were selected for retrospective analysis. The AIP was calculated as a logarithmically converted ratio of triglycerides (TG) to high-density lipoprotein-cholesterol (HDL-C). The participants were divided into AIP quartile groups (Q1-Q4). Logistic regression models and restricted cubic spline analyses were used to examine the association of the AIP with carotid atherosclerosis. Stratified analyses were applied to control for confounding factors. The incremental predictive value of the AIP was further assessed.
Results
After adjusting for traditional risk factors, an increased AIP was associated with a higher rate of carotid atherosclerosis (CA), increased carotid intima-media thickness (CIMT), and plaques [odds ratio, OR (95% confidence interval, CI): 1.06 (1.04, 1.08), 1.07 (1.05, 1.09), and 1.04 (1.02, 1.06) per 1-SD increase in the AIP, respectively]. Compared with those participants in the quartile 1 group, those in the quartile 4 group had a greater risk of CA [OR 1.18, 95% CI (1.12, 1.25)], increased CIMT [OR 1.20, 95% CI (1.13, 1.26)], and plaques [OR 1.13, 95% CI (1.06, 1.19)]. However, we did not observe an association between the AIP and stenosis [0.97 (0.77, 1.23), p for trend = 0.758]. Restricted cubic spline analyses also showed a cumulative increase in the risk of CA, increased CIMT, and plaques but not stenosis severity (> 50%) with an increase of the AIP. Subgroup analyses showed that a more significant association between the AIP and the prevalence of increased CA was detected in younger subjects (aged < 60 years) with a body mass index (BMI) of ≥ 24 and fewer comorbidities. Additionally, the AIP provided incremental predictive capacity over established risk factors for CA, as shown by an improvement in the net reclassification index (NRI) and integrated discrimination index (IDI) (all P < 0.05).
Conclusions
An elevated AIP in a community-based population is associated with a higher rate of CA. the AIP could serve as a potential biomarker for CA risk assessment. |
|---|---|
| AbstractList | Abstract Background The atherogenic index of plasma (AIP) is an important alternative metabolic biomarker of atherosclerosis and cardiovascular diseases. Nevertheless, the correlation between the AIP and carotid atherosclerosis is unknown among the general population. Methods A total of 52,380 community residents, aged ≥ 40 years who underwentcervical vascular ultrasound from December 2017 to December 2020 in Hunan China, were selected for retrospective analysis. The AIP was calculated as a logarithmically converted ratio of triglycerides (TG) to high-density lipoprotein-cholesterol (HDL-C). The participants were divided into AIP quartile groups (Q1-Q4). Logistic regression models and restricted cubic spline analyses were used to examine the association of the AIP with carotid atherosclerosis. Stratified analyses were applied to control for confounding factors. The incremental predictive value of the AIP was further assessed. Results After adjusting for traditional risk factors, an increased AIP was associated with a higher rate of carotid atherosclerosis (CA), increased carotid intima-media thickness (CIMT), and plaques [odds ratio, OR (95% confidence interval, CI): 1.06 (1.04, 1.08), 1.07 (1.05, 1.09), and 1.04 (1.02, 1.06) per 1-SD increase in the AIP, respectively]. Compared with those participants in the quartile 1 group, those in the quartile 4 group had a greater risk of CA [OR 1.18, 95% CI (1.12, 1.25)], increased CIMT [OR 1.20, 95% CI (1.13, 1.26)], and plaques [OR 1.13, 95% CI (1.06, 1.19)]. However, we did not observe an association between the AIP and stenosis [0.97 (0.77, 1.23), p for trend = 0.758]. Restricted cubic spline analyses also showed a cumulative increase in the risk of CA, increased CIMT, and plaques but not stenosis severity (> 50%) with an increase of the AIP. Subgroup analyses showed that a more significant association between the AIP and the prevalence of increased CA was detected in younger subjects (aged < 60 years) with a body mass index (BMI) of ≥ 24 and fewer comorbidities. Additionally, the AIP provided incremental predictive capacity over established risk factors for CA, as shown by an improvement in the net reclassification index (NRI) and integrated discrimination index (IDI) (all P < 0.05). Conclusions An elevated AIP in a community-based population is associated with a higher rate of CA. the AIP could serve as a potential biomarker for CA risk assessment. The atherogenic index of plasma (AIP) is an important alternative metabolic biomarker of atherosclerosis and cardiovascular diseases. Nevertheless, the correlation between the AIP and carotid atherosclerosis is unknown among the general population. A total of 52,380 community residents, aged ≥ 40 years who underwentcervical vascular ultrasound from December 2017 to December 2020 in Hunan China, were selected for retrospective analysis. The AIP was calculated as a logarithmically converted ratio of triglycerides (TG) to high-density lipoprotein-cholesterol (HDL-C). The participants were divided into AIP quartile groups (Q1-Q4). Logistic regression models and restricted cubic spline analyses were used to examine the association of the AIP with carotid atherosclerosis. Stratified analyses were applied to control for confounding factors. The incremental predictive value of the AIP was further assessed. After adjusting for traditional risk factors, an increased AIP was associated with a higher rate of carotid atherosclerosis (CA), increased carotid intima-media thickness (CIMT), and plaques [odds ratio, OR (95% confidence interval, CI): 1.06 (1.04, 1.08), 1.07 (1.05, 1.09), and 1.04 (1.02, 1.06) per 1-SD increase in the AIP, respectively]. Compared with those participants in the quartile 1 group, those in the quartile 4 group had a greater risk of CA [OR 1.18, 95% CI (1.12, 1.25)], increased CIMT [OR 1.20, 95% CI (1.13, 1.26)], and plaques [OR 1.13, 95% CI (1.06, 1.19)]. However, we did not observe an association between the AIP and stenosis [0.97 (0.77, 1.23), p for trend = 0.758]. Restricted cubic spline analyses also showed a cumulative increase in the risk of CA, increased CIMT, and plaques but not stenosis severity (> 50%) with an increase of the AIP. Subgroup analyses showed that a more significant association between the AIP and the prevalence of increased CA was detected in younger subjects (aged < 60 years) with a body mass index (BMI) of ≥ 24 and fewer comorbidities. Additionally, the AIP provided incremental predictive capacity over established risk factors for CA, as shown by an improvement in the net reclassification index (NRI) and integrated discrimination index (IDI) (all P < 0.05). An elevated AIP in a community-based population is associated with a higher rate of CA. the AIP could serve as a potential biomarker for CA risk assessment. The atherogenic index of plasma (AIP) is an important alternative metabolic biomarker of atherosclerosis and cardiovascular diseases. Nevertheless, the correlation between the AIP and carotid atherosclerosis is unknown among the general population.BACKGROUNDThe atherogenic index of plasma (AIP) is an important alternative metabolic biomarker of atherosclerosis and cardiovascular diseases. Nevertheless, the correlation between the AIP and carotid atherosclerosis is unknown among the general population.A total of 52,380 community residents, aged ≥ 40 years who underwentcervical vascular ultrasound from December 2017 to December 2020 in Hunan China, were selected for retrospective analysis. The AIP was calculated as a logarithmically converted ratio of triglycerides (TG) to high-density lipoprotein-cholesterol (HDL-C). The participants were divided into AIP quartile groups (Q1-Q4). Logistic regression models and restricted cubic spline analyses were used to examine the association of the AIP with carotid atherosclerosis. Stratified analyses were applied to control for confounding factors. The incremental predictive value of the AIP was further assessed.METHODSA total of 52,380 community residents, aged ≥ 40 years who underwentcervical vascular ultrasound from December 2017 to December 2020 in Hunan China, were selected for retrospective analysis. The AIP was calculated as a logarithmically converted ratio of triglycerides (TG) to high-density lipoprotein-cholesterol (HDL-C). The participants were divided into AIP quartile groups (Q1-Q4). Logistic regression models and restricted cubic spline analyses were used to examine the association of the AIP with carotid atherosclerosis. Stratified analyses were applied to control for confounding factors. The incremental predictive value of the AIP was further assessed.After adjusting for traditional risk factors, an increased AIP was associated with a higher rate of carotid atherosclerosis (CA), increased carotid intima-media thickness (CIMT), and plaques [odds ratio, OR (95% confidence interval, CI): 1.06 (1.04, 1.08), 1.07 (1.05, 1.09), and 1.04 (1.02, 1.06) per 1-SD increase in the AIP, respectively]. Compared with those participants in the quartile 1 group, those in the quartile 4 group had a greater risk of CA [OR 1.18, 95% CI (1.12, 1.25)], increased CIMT [OR 1.20, 95% CI (1.13, 1.26)], and plaques [OR 1.13, 95% CI (1.06, 1.19)]. However, we did not observe an association between the AIP and stenosis [0.97 (0.77, 1.23), p for trend = 0.758]. Restricted cubic spline analyses also showed a cumulative increase in the risk of CA, increased CIMT, and plaques but not stenosis severity (> 50%) with an increase of the AIP. Subgroup analyses showed that a more significant association between the AIP and the prevalence of increased CA was detected in younger subjects (aged < 60 years) with a body mass index (BMI) of ≥ 24 and fewer comorbidities. Additionally, the AIP provided incremental predictive capacity over established risk factors for CA, as shown by an improvement in the net reclassification index (NRI) and integrated discrimination index (IDI) (all P < 0.05).RESULTSAfter adjusting for traditional risk factors, an increased AIP was associated with a higher rate of carotid atherosclerosis (CA), increased carotid intima-media thickness (CIMT), and plaques [odds ratio, OR (95% confidence interval, CI): 1.06 (1.04, 1.08), 1.07 (1.05, 1.09), and 1.04 (1.02, 1.06) per 1-SD increase in the AIP, respectively]. Compared with those participants in the quartile 1 group, those in the quartile 4 group had a greater risk of CA [OR 1.18, 95% CI (1.12, 1.25)], increased CIMT [OR 1.20, 95% CI (1.13, 1.26)], and plaques [OR 1.13, 95% CI (1.06, 1.19)]. However, we did not observe an association between the AIP and stenosis [0.97 (0.77, 1.23), p for trend = 0.758]. Restricted cubic spline analyses also showed a cumulative increase in the risk of CA, increased CIMT, and plaques but not stenosis severity (> 50%) with an increase of the AIP. Subgroup analyses showed that a more significant association between the AIP and the prevalence of increased CA was detected in younger subjects (aged < 60 years) with a body mass index (BMI) of ≥ 24 and fewer comorbidities. Additionally, the AIP provided incremental predictive capacity over established risk factors for CA, as shown by an improvement in the net reclassification index (NRI) and integrated discrimination index (IDI) (all P < 0.05).An elevated AIP in a community-based population is associated with a higher rate of CA. the AIP could serve as a potential biomarker for CA risk assessment.CONCLUSIONSAn elevated AIP in a community-based population is associated with a higher rate of CA. the AIP could serve as a potential biomarker for CA risk assessment. Background The atherogenic index of plasma (AIP) is an important alternative metabolic biomarker of atherosclerosis and cardiovascular diseases. Nevertheless, the correlation between the AIP and carotid atherosclerosis is unknown among the general population. Methods A total of 52,380 community residents, aged ≥ 40 years who underwentcervical vascular ultrasound from December 2017 to December 2020 in Hunan China, were selected for retrospective analysis. The AIP was calculated as a logarithmically converted ratio of triglycerides (TG) to high-density lipoprotein-cholesterol (HDL-C). The participants were divided into AIP quartile groups (Q1-Q4). Logistic regression models and restricted cubic spline analyses were used to examine the association of the AIP with carotid atherosclerosis. Stratified analyses were applied to control for confounding factors. The incremental predictive value of the AIP was further assessed. Results After adjusting for traditional risk factors, an increased AIP was associated with a higher rate of carotid atherosclerosis (CA), increased carotid intima-media thickness (CIMT), and plaques [odds ratio, OR (95% confidence interval, CI): 1.06 (1.04, 1.08), 1.07 (1.05, 1.09), and 1.04 (1.02, 1.06) per 1-SD increase in the AIP, respectively]. Compared with those participants in the quartile 1 group, those in the quartile 4 group had a greater risk of CA [OR 1.18, 95% CI (1.12, 1.25)], increased CIMT [OR 1.20, 95% CI (1.13, 1.26)], and plaques [OR 1.13, 95% CI (1.06, 1.19)]. However, we did not observe an association between the AIP and stenosis [0.97 (0.77, 1.23), p for trend = 0.758]. Restricted cubic spline analyses also showed a cumulative increase in the risk of CA, increased CIMT, and plaques but not stenosis severity (> 50%) with an increase of the AIP. Subgroup analyses showed that a more significant association between the AIP and the prevalence of increased CA was detected in younger subjects (aged < 60 years) with a body mass index (BMI) of ≥ 24 and fewer comorbidities. Additionally, the AIP provided incremental predictive capacity over established risk factors for CA, as shown by an improvement in the net reclassification index (NRI) and integrated discrimination index (IDI) (all P < 0.05). Conclusions An elevated AIP in a community-based population is associated with a higher rate of CA. the AIP could serve as a potential biomarker for CA risk assessment. BackgroundThe atherogenic index of plasma (AIP) is an important alternative metabolic biomarker of atherosclerosis and cardiovascular diseases. Nevertheless, the correlation between the AIP and carotid atherosclerosis is unknown among the general population.MethodsA total of 52,380 community residents, aged ≥ 40 years who underwentcervical vascular ultrasound from December 2017 to December 2020 in Hunan China, were selected for retrospective analysis. The AIP was calculated as a logarithmically converted ratio of triglycerides (TG) to high-density lipoprotein-cholesterol (HDL-C). The participants were divided into AIP quartile groups (Q1-Q4). Logistic regression models and restricted cubic spline analyses were used to examine the association of the AIP with carotid atherosclerosis. Stratified analyses were applied to control for confounding factors. The incremental predictive value of the AIP was further assessed.ResultsAfter adjusting for traditional risk factors, an increased AIP was associated with a higher rate of carotid atherosclerosis (CA), increased carotid intima-media thickness (CIMT), and plaques [odds ratio, OR (95% confidence interval, CI): 1.06 (1.04, 1.08), 1.07 (1.05, 1.09), and 1.04 (1.02, 1.06) per 1-SD increase in the AIP, respectively]. Compared with those participants in the quartile 1 group, those in the quartile 4 group had a greater risk of CA [OR 1.18, 95% CI (1.12, 1.25)], increased CIMT [OR 1.20, 95% CI (1.13, 1.26)], and plaques [OR 1.13, 95% CI (1.06, 1.19)]. However, we did not observe an association between the AIP and stenosis [0.97 (0.77, 1.23), p for trend = 0.758]. Restricted cubic spline analyses also showed a cumulative increase in the risk of CA, increased CIMT, and plaques but not stenosis severity (> 50%) with an increase of the AIP. Subgroup analyses showed that a more significant association between the AIP and the prevalence of increased CA was detected in younger subjects (aged < 60 years) with a body mass index (BMI) of ≥ 24 and fewer comorbidities. Additionally, the AIP provided incremental predictive capacity over established risk factors for CA, as shown by an improvement in the net reclassification index (NRI) and integrated discrimination index (IDI) (all P < 0.05).ConclusionsAn elevated AIP in a community-based population is associated with a higher rate of CA. the AIP could serve as a potential biomarker for CA risk assessment. |
| ArticleNumber | 125 |
| Author | Huang, Qing Feng, Jie Wei, Minping Liu, Zunjing Huang, Qin Xia, Jian Liu, Zeyu |
| Author_xml | – sequence: 1 givenname: Qin surname: Huang fullname: Huang, Qin organization: Department of Neurology, Xiangya Hospital, Central South University, Department of Neurology, Peking University people’s hospital – sequence: 2 givenname: Zeyu surname: Liu fullname: Liu, Zeyu organization: Department of Neurology, Xiangya Hospital, Central South University – sequence: 3 givenname: Minping surname: Wei fullname: Wei, Minping organization: Department of Neurology, Xiangya Hospital, Central South University – sequence: 4 givenname: Qing surname: Huang fullname: Huang, Qing organization: Department of Neurology, Xiangya Hospital, Central South University – sequence: 5 givenname: Jie surname: Feng fullname: Feng, Jie organization: Department of Neurology, Xiangya Hospital, Central South University – sequence: 6 givenname: Zunjing surname: Liu fullname: Liu, Zunjing organization: Department of Neurology, Peking University people’s hospital – sequence: 7 givenname: Jian surname: Xia fullname: Xia, Jian email: xjian1216@csu.edu.cn organization: Department of Neurology, Xiangya Hospital, Central South University, Clinical Research Center for Cerebrovascular Disease of Hunan Province, Central South University, National Clinical Research Center for Geriatric Disorders, Xiangya Hospital, Central South University |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/37244995$$D View this record in MEDLINE/PubMed |
| BookMark | eNp9kktv1DAUhSNURB_wB1igSGzYBPxK7LBBaNRCpUpsytq6sZ2JR4k92A4iK_46nkfpY9FFHPvmO0cnvve8OHHemaJ4i9FHjEXzKWLSUlohkh8saFstL4ozzHhdEcHQyYP9aXEe4wYhzEWDXxWnlBPG2rY-K_7eDqaENJjg18ZZVVqnzZ_S9-V2hDhBCU6XCoJPVh-5qMbdamNmSyiVn6bZ2bSUW7-dR0jWu8-5fn-qOogmu_jBh1TGNOtlJ10N1sHr4mUPYzRvju-L4ufV5e3qe3Xz49v16utNpRokUqUNVYRrTgmGpquZ5rxDLZim6UQLvIaeMtorw-uuVoJwpZhSFEytASjVml4U1wdf7WEjt8FOEBbpwcp9wYe1hJBs_jXZ9Lrl0HLDRMM6ioVR-eIYNIixDvdd9vpy8NrO3WS0Mi4FGB-ZPv7i7CDX_rfEiJAatSI7fDg6BP9rNjHJyUZlxhGc8XOURBCECEdoh75_gm78HFy-qx3FUUMQQZl69zDS_yx3jc6AOAAqty4G00tl0747OaEdczS5myl5mCmZZ0ruZ0ouWUqeSO_cnxXRgyhm2K1NuI_9jOofhFXiGQ |
| CitedBy_id | crossref_primary_10_1186_s12933_024_02350_8 crossref_primary_10_1016_j_arteri_2025_500772 crossref_primary_10_4103_njcp_njcp_321_24 crossref_primary_10_1186_s12933_024_02375_z crossref_primary_10_1186_s12933_023_01977_3 crossref_primary_10_1186_s12933_024_02162_w crossref_primary_10_1186_s12933_024_02370_4 crossref_primary_10_1186_s12872_025_04500_6 crossref_primary_10_1016_j_jstrokecerebrovasdis_2024_108193 crossref_primary_10_1186_s12876_024_03190_2 crossref_primary_10_3389_fendo_2024_1393644 crossref_primary_10_1186_s12933_023_02108_8 crossref_primary_10_1136_bmjopen_2023_083526 crossref_primary_10_3390_ph16101396 crossref_primary_10_14366_usg_24019 crossref_primary_10_1186_s12933_024_02314_y crossref_primary_10_1186_s12933_024_02359_z crossref_primary_10_1186_s12872_025_04491_4 crossref_primary_10_3390_nu16162613 crossref_primary_10_4236_jbm_2024_121002 crossref_primary_10_1186_s12933_024_02532_4 crossref_primary_10_5812_jcrps_140668 crossref_primary_10_1093_lifemedi_lnad033 crossref_primary_10_3390_nu16050672 crossref_primary_10_1186_s12933_023_02044_7 crossref_primary_10_3389_fendo_2024_1428830 crossref_primary_10_1186_s12933_025_02654_3 crossref_primary_10_1080_07853890_2024_2442532 crossref_primary_10_3389_fnut_2025_1511952 crossref_primary_10_1016_j_sleep_2025_03_017 crossref_primary_10_1016_j_ecoenv_2024_117395 crossref_primary_10_1080_0886022X_2024_2407885 |
| Cites_doi | 10.1186/1741-7015-11-117 10.1016/j.maturitas.2021.03.008 10.1001/jama.288.1.49 10.7326/0003-4819-147-8-200710160-00010 10.1016/j.arcmed.2019.08.009 10.1161/STROKEAHA.117.016921 10.1161/JAHA.118.008701 10.1038/s41598-017-13267-6 10.1111/brv.12866 10.1186/s12933-023-01740-8 10.1016/S0009-9120(01)00263-6 10.1007/s10072-022-06472-3 10.1161/JAHA.122.027586 10.1016/j.jcmg.2013.11.014 10.1161/circ.106.25.3143 10.1093/eurheartj/ehw106 10.1016/j.jvs.2019.04.488 10.1038/s41569-021-00647-9 10.1186/s12933-022-01459-y 10.3389/fendo.2022.1023867 10.3390/ijms23095089 10.1093/eurheartj/ehw272 10.1016/j.lanwpc.2022.100550 10.1177/1747493020913557 10.1161/01.STR.0000147723.52033.9e 10.1016/j.jacc.2020.11.010 10.1016/j.jacc.2009.11.075 10.1016/j.mayocp.2016.12.018 10.1210/er.2018-00184 10.1093/eurheartj/ehq185 10.1373/clinchem.2004.033175 10.1007/s10067-018-4027-0 10.1016/j.atherosclerosis.2011.06.044 10.1186/s12933-022-01522-8 10.1186/s12944-019-1043-2 10.1016/S2214-109X(20)30117-0 10.1007/s11883-011-0219-7 10.1016/j.jstrokecerebrovasdis.2020.105351 10.1161/STROKEAHA.107.487264 10.1080/08998280.2020.1799479 10.1186/s12933-022-01627-0 10.1016/j.atherosclerosis.2021.03.009 10.4070/kcj.2010.40.1.1 10.1186/s12944-018-0828-z 10.1016/S1474-4422(21)00252-0 10.1186/s12933-021-01393-5 10.1186/s12933-022-01570-0 10.3389/fneur.2021.679415 10.1016/j.jacc.2014.09.042 10.1159/000343145 10.1016/j.cjca.2022.03.009 |
| ContentType | Journal Article |
| Copyright | The Author(s) 2023 2023. The Author(s). 2023. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. |
| Copyright_xml | – notice: The Author(s) 2023 – notice: 2023. The Author(s). – notice: 2023. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. |
| DBID | C6C AAYXX CITATION CGR CUY CVF ECM EIF NPM 3V. 7T5 7X7 7XB 88E 8FI 8FJ 8FK ABUWG AFKRA AZQEC BENPR CCPQU DWQXO FYUFA GHDGH H94 K9. M0S M1P PHGZM PHGZT PIMPY PJZUB PKEHL PPXIY PQEST PQQKQ PQUKI PRINS 7X8 5PM DOA |
| DOI | 10.1186/s12933-023-01839-y |
| DatabaseName | Springer Nature Open Access Journals CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed ProQuest Central (Corporate) Immunology Abstracts Health & Medical Collection ProQuest Central (purchase pre-March 2016) Medical Database (Alumni Edition) ProQuest Hospital Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Central (Alumni) ProQuest Central UK/Ireland ProQuest Central Essentials ProQuest Central ProQuest One Community College ProQuest Central Korea Health Research Premium Collection Health Research Premium Collection (Alumni) AIDS and Cancer Research Abstracts ProQuest Health & Medical Complete (Alumni) ProQuest Health & Medical Collection Medical Database ProQuest Central Premium ProQuest One Academic (New) Publicly Available Content Database ProQuest Health & Medical Research Collection ProQuest One Academic Middle East (New) ProQuest One Health & Nursing ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Academic ProQuest One Academic UKI Edition ProQuest Central China MEDLINE - Academic PubMed Central (Full Participant titles) DOAJ Directory of Open Access Journals |
| DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) Publicly Available Content Database ProQuest One Academic Middle East (New) ProQuest Central Essentials ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) ProQuest One Community College ProQuest One Health & Nursing ProQuest Central China ProQuest Central Health Research Premium Collection Health and Medicine Complete (Alumni Edition) ProQuest Central Korea Health & Medical Research Collection AIDS and Cancer Research Abstracts ProQuest Central (New) ProQuest Medical Library (Alumni) ProQuest One Academic Eastern Edition ProQuest Hospital Collection Health Research Premium Collection (Alumni) ProQuest Hospital Collection (Alumni) ProQuest Health & Medical Complete ProQuest Medical Library ProQuest One Academic UKI Edition Immunology Abstracts ProQuest One Academic ProQuest One Academic (New) ProQuest Central (Alumni) MEDLINE - Academic |
| DatabaseTitleList | MEDLINE MEDLINE - Academic Publicly Available Content Database |
| Database_xml | – sequence: 1 dbid: C6C name: Springer Nature OA Free Journals url: http://www.springeropen.com/ sourceTypes: Publisher – sequence: 2 dbid: DOA name: DOAJ Directory of Open Access Journals url: https://www.doaj.org/ sourceTypes: Open Website – sequence: 3 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 4 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database – sequence: 5 dbid: BENPR name: ProQuest Central url: http://www.proquest.com/pqcentral?accountid=15518 sourceTypes: Aggregation Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Medicine |
| EISSN | 1475-2840 |
| EndPage | 13 |
| ExternalDocumentID | oai_doaj_org_article_6fd97a97e4864b318ec0174a6044b1fb PMC10225098 37244995 10_1186_s12933_023_01839_y |
| Genre | Research Support, Non-U.S. Gov't Journal Article |
| GeographicLocations | China |
| GeographicLocations_xml | – name: China |
| GrantInformation_xml | – fundername: the Provincial Key Plan for Research and Development of Hunan grantid: 2020SK2067 – fundername: National Key Research and Development Projects grantid: 2022YFC3602400 and 2022YFC3602401 – fundername: National Natural Science Foundation of China grantid: 82271369 – fundername: Project Program of National Clinical Research Center for Geriatric Disorders grantid: 2020LNJJ16 – fundername: ; grantid: 2020SK2067 – fundername: ; grantid: 2020LNJJ16 – fundername: ; grantid: 82271369 – fundername: ; grantid: 2022YFC3602400 and 2022YFC3602401 |
| GroupedDBID | --- 0R~ 29B 2WC 53G 5GY 5VS 6J9 7X7 88E 8FI 8FJ AAFWJ AAJSJ AASML ABDBF ABUWG ACGFO ACGFS ACIHN ACIWK ACPRK ACUHS ADBBV ADRAZ ADUKV AEAQA AENEX AFKRA AFPKN AFRAH AHBYD AHMBA AHYZX ALMA_UNASSIGNED_HOLDINGS AMKLP AMTXH AOIJS BAPOH BAWUL BCNDV BENPR BFQNJ BMC BPHCQ BVXVI C6C CCPQU CS3 DIK DU5 E3Z EAD EAP EAS EBD EBLON EBS EMB EMK EMOBN ESX F5P FYUFA GROUPED_DOAJ GX1 HMCUK HYE IAO IHR INH INR ITC KQ8 M1P M48 M~E O5R O5S OK1 OVT P2P PGMZT PHGZM PHGZT PIMPY PJZUB PPXIY PQQKQ PROAC PSQYO PUEGO RBZ RNS ROL RPM RSV SMD SOJ SV3 TR2 TUS UKHRP W2D WOQ WOW XSB AAYXX ALIPV CITATION -5E -5G -A0 -BR 3V. ACRMQ ADINQ C24 CGR CUY CVF ECM EIF FRP NPM 7T5 7XB 8FK AZQEC DWQXO H94 K9. PKEHL PQEST PQUKI PRINS 7X8 5PM |
| ID | FETCH-LOGICAL-c608t-de3c27d7321a6b54d77b09ae66b89a75af343fce75b5c827cc4cc3ae5daa33dd3 |
| IEDL.DBID | M48 |
| ISSN | 1475-2840 |
| IngestDate | Wed Aug 27 01:25:15 EDT 2025 Thu Aug 21 18:37:37 EDT 2025 Thu Sep 04 20:28:05 EDT 2025 Sun Sep 07 03:28:13 EDT 2025 Thu Jan 02 22:51:37 EST 2025 Tue Jul 01 04:19:59 EDT 2025 Thu Apr 24 23:10:59 EDT 2025 Sat Sep 06 07:29:30 EDT 2025 |
| IsDoiOpenAccess | true |
| IsOpenAccess | true |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 1 |
| Keywords | Carotid plaque Atherogenic index of plasma Carotid atherosclerosis Carotid intima-media thickness |
| Language | English |
| License | 2023. The Author(s). Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c608t-de3c27d7321a6b54d77b09ae66b89a75af343fce75b5c827cc4cc3ae5daa33dd3 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 |
| OpenAccessLink | http://journals.scholarsportal.info/openUrl.xqy?doi=10.1186/s12933-023-01839-y |
| PMID | 37244995 |
| PQID | 2827062020 |
| PQPubID | 42570 |
| PageCount | 13 |
| ParticipantIDs | doaj_primary_oai_doaj_org_article_6fd97a97e4864b318ec0174a6044b1fb pubmedcentral_primary_oai_pubmedcentral_nih_gov_10225098 proquest_miscellaneous_2820027008 proquest_journals_2827062020 pubmed_primary_37244995 crossref_citationtrail_10_1186_s12933_023_01839_y crossref_primary_10_1186_s12933_023_01839_y springer_journals_10_1186_s12933_023_01839_y |
| ProviderPackageCode | CITATION AAYXX |
| PublicationCentury | 2000 |
| PublicationDate | 2023-05-27 |
| PublicationDateYYYYMMDD | 2023-05-27 |
| PublicationDate_xml | – month: 05 year: 2023 text: 2023-05-27 day: 27 |
| PublicationDecade | 2020 |
| PublicationPlace | London |
| PublicationPlace_xml | – name: London – name: England |
| PublicationTitle | Cardiovascular diabetology |
| PublicationTitleAbbrev | Cardiovasc Diabetol |
| PublicationTitleAlternate | Cardiovasc Diabetol |
| PublicationYear | 2023 |
| Publisher | BioMed Central BMC |
| Publisher_xml | – name: BioMed Central – name: BMC |
| References | P Song (1839_CR13) 2020; 8 DH O’Leary (1839_CR9) 2010; 31 T-T Wu (1839_CR49) 2018; 17 SH Johnsen (1839_CR36) 2007; 38 B Lioy (1839_CR54) 2023; 11 B Fan (1839_CR41) 2022; 38 V Nambi (1839_CR11) 2010; 55 1839_CR37 JC Fernandez-Macias (1839_CR20) 2019; 50 UK Sampson (1839_CR17) 2012; 14 1839_CR32 PB Sandesara (1839_CR14) 2019; 40 E Cure (1839_CR40) 2018; 37 M Dobiasova (1839_CR38) 2001; 34 M Dobiasova (1839_CR19) 2004; 50 JL Hernandez (1839_CR51) 2021; 148 S Placzkowska (1839_CR47) 2022; 23 1839_CR53 J Guo (1839_CR44) 2021; 12 H Gardener (1839_CR10) 2017; 48 K-B Won (1839_CR25) 2021; 324 1839_CR46 YM Hong (1839_CR4) 2010; 40 Q Xiang (1839_CR15) 2022; 97 B-H Chao (1839_CR26) 2021; 16 1839_CR43 A Kitamura (1839_CR12) 2004; 35 RS Rosenson (1839_CR18) 2014; 64 O Raitakari (1839_CR34) 2022; 19 G Cai (1839_CR45) 2019; 18 Z Zhao (1839_CR42) 2023; 44 Y Inaba (1839_CR35) 2012; 220 M Dobiasova (1839_CR52) 2006; 52 Y Zheng (1839_CR22) 2022; 21 TZ Naqvi (1839_CR8) 2014; 7 AL Catapano (1839_CR16) 2016; 37 E von Elm (1839_CR27) 2007; 147 X Tang (1839_CR30) 2022; 13 Y Zhu (1839_CR31) 2022; 21 W-J Tu (1839_CR28) 2023; 6 VL Feigin (1839_CR2) 2021; 20 GA Roth (1839_CR1) 2020; 76 MF Piepoli (1839_CR5) 2016; 37 W Ni (1839_CR48) 2017; 7 SM Grundy (1839_CR39) 2002; 106 W-J Tu (1839_CR29) 2022; 28 Y Shi (1839_CR23) 2023; 22 X Wang (1839_CR7) 2018; 7 L Fu (1839_CR21) 2021; 20 SH Kim (1839_CR24) 2022; 21 E Martinez (1839_CR6) 2020; 71 W Li (1839_CR33) 2022; 21 D Grady (1839_CR50) 2002; 288 1839_CR3 |
| References_xml | – ident: 1839_CR3 doi: 10.1186/1741-7015-11-117 – volume: 148 start-page: 1 year: 2021 ident: 1839_CR51 publication-title: Maturitas doi: 10.1016/j.maturitas.2021.03.008 – volume: 288 start-page: 49 issue: 1 year: 2002 ident: 1839_CR50 publication-title: Jama-Journal of the American Medical Association doi: 10.1001/jama.288.1.49 – volume: 147 start-page: 573 issue: 8 year: 2007 ident: 1839_CR27 publication-title: Annals of Internal Medicine doi: 10.7326/0003-4819-147-8-200710160-00010 – volume: 50 start-page: 285 issue: 5 year: 2019 ident: 1839_CR20 publication-title: Archives of Medical Research doi: 10.1016/j.arcmed.2019.08.009 – volume: 48 start-page: 1855 issue: 7 year: 2017 ident: 1839_CR10 publication-title: Stroke doi: 10.1161/STROKEAHA.117.016921 – volume: 7 start-page: e008701 issue: 8 year: 2018 ident: 1839_CR7 publication-title: Journal of the American Heart Association doi: 10.1161/JAHA.118.008701 – volume: 7 start-page: 13207 issue: 1 year: 2017 ident: 1839_CR48 publication-title: Scientific Reports doi: 10.1038/s41598-017-13267-6 – volume: 97 start-page: 1844 issue: 5 year: 2022 ident: 1839_CR15 publication-title: Biological Reviews doi: 10.1111/brv.12866 – volume: 22 start-page: 19 issue: 1 year: 2023 ident: 1839_CR23 publication-title: Cardiovascular Diabetology doi: 10.1186/s12933-023-01740-8 – volume: 34 start-page: 583 issue: 7 year: 2001 ident: 1839_CR38 publication-title: Clinical Biochemistry doi: 10.1016/S0009-9120(01)00263-6 – volume: 44 start-page: 835 issue: 3 year: 2023 ident: 1839_CR42 publication-title: Neurological Sciences doi: 10.1007/s10072-022-06472-3 – ident: 1839_CR37 doi: 10.1161/JAHA.122.027586 – volume: 52 start-page: 64 issue: 1 year: 2006 ident: 1839_CR52 publication-title: Vnitrni lekarstvi – volume: 7 start-page: 1025 issue: 10 year: 2014 ident: 1839_CR8 publication-title: Jacc-Cardiovascular Imaging doi: 10.1016/j.jcmg.2013.11.014 – volume: 6 start-page: e231455-e231455 issue: 3 year: 2023 ident: 1839_CR28 publication-title: JAMA network open – volume: 106 start-page: 3143 issue: 25 year: 2002 ident: 1839_CR39 publication-title: Circulation doi: 10.1161/circ.106.25.3143 – volume: 37 start-page: 2315 issue: 29 year: 2016 ident: 1839_CR5 publication-title: European Heart Journal doi: 10.1093/eurheartj/ehw106 – volume: 71 start-page: 329 issue: 1 year: 2020 ident: 1839_CR6 publication-title: Journal of Vascular Surgery doi: 10.1016/j.jvs.2019.04.488 – volume: 19 start-page: 543 issue: 8 year: 2022 ident: 1839_CR34 publication-title: Nature Reviews Cardiology doi: 10.1038/s41569-021-00647-9 – volume: 21 start-page: 29 issue: 1 year: 2022 ident: 1839_CR22 publication-title: Cardiovascular Diabetology doi: 10.1186/s12933-022-01459-y – volume: 13 start-page: 1023867 year: 2022 ident: 1839_CR30 publication-title: Frontiers in Endocrinology doi: 10.3389/fendo.2022.1023867 – volume: 23 start-page: 5089 issue: 9 year: 2022 ident: 1839_CR47 publication-title: International Journal of Molecular Sciences doi: 10.3390/ijms23095089 – volume: 37 start-page: 2999 issue: 39 year: 2016 ident: 1839_CR16 publication-title: European Heart Journal doi: 10.1093/eurheartj/ehw272 – volume: 28 start-page: 100550 year: 2022 ident: 1839_CR29 publication-title: Lancet Regional Health-Western Pacific doi: 10.1016/j.lanwpc.2022.100550 – volume: 16 start-page: 265 issue: 3 year: 2021 ident: 1839_CR26 publication-title: International Journal of Stroke doi: 10.1177/1747493020913557 – volume: 35 start-page: 2788 issue: 12 year: 2004 ident: 1839_CR12 publication-title: Stroke doi: 10.1161/01.STR.0000147723.52033.9e – volume: 76 start-page: 2982 issue: 25 year: 2020 ident: 1839_CR1 publication-title: Journal of the American College of Cardiology doi: 10.1016/j.jacc.2020.11.010 – volume: 55 start-page: 1600 issue: 15 year: 2010 ident: 1839_CR11 publication-title: Journal of the American College of Cardiology doi: 10.1016/j.jacc.2009.11.075 – ident: 1839_CR46 doi: 10.1016/j.mayocp.2016.12.018 – volume: 40 start-page: 537 issue: 2 year: 2019 ident: 1839_CR14 publication-title: Endocrine Reviews doi: 10.1210/er.2018-00184 – volume: 31 start-page: 1682 issue: 14 year: 2010 ident: 1839_CR9 publication-title: European Heart Journal doi: 10.1093/eurheartj/ehq185 – volume: 50 start-page: 1113 issue: 7 year: 2004 ident: 1839_CR19 publication-title: Clinical Chemistry doi: 10.1373/clinchem.2004.033175 – volume: 37 start-page: 1273 issue: 5 year: 2018 ident: 1839_CR40 publication-title: Clinical Rheumatology doi: 10.1007/s10067-018-4027-0 – volume: 220 start-page: 128 issue: 1 year: 2012 ident: 1839_CR35 publication-title: Atherosclerosis doi: 10.1016/j.atherosclerosis.2011.06.044 – volume: 21 start-page: 81 issue: 1 year: 2022 ident: 1839_CR24 publication-title: Cardiovascular Diabetology doi: 10.1186/s12933-022-01522-8 – volume: 18 start-page: 99 issue: 1 year: 2019 ident: 1839_CR45 publication-title: Lipids in Health and Disease doi: 10.1186/s12944-019-1043-2 – volume: 8 start-page: E721-E729 issue: 5 year: 2020 ident: 1839_CR13 publication-title: Lancet Global Health doi: 10.1016/S2214-109X(20)30117-0 – volume: 14 start-page: 1 issue: 1 year: 2012 ident: 1839_CR17 publication-title: Current Atherosclerosis Reports doi: 10.1007/s11883-011-0219-7 – ident: 1839_CR43 doi: 10.1016/j.jstrokecerebrovasdis.2020.105351 – volume: 38 start-page: 2873 issue: 11 year: 2007 ident: 1839_CR36 publication-title: Stroke doi: 10.1161/STROKEAHA.107.487264 – ident: 1839_CR53 doi: 10.1080/08998280.2020.1799479 – volume: 21 start-page: 186 issue: 1 year: 2022 ident: 1839_CR31 publication-title: Cardiovascular Diabetology doi: 10.1186/s12933-022-01627-0 – volume: 324 start-page: 46 year: 2021 ident: 1839_CR25 publication-title: Atherosclerosis doi: 10.1016/j.atherosclerosis.2021.03.009 – volume: 40 start-page: 1 issue: 1 year: 2010 ident: 1839_CR4 publication-title: Korean circulation journal doi: 10.4070/kcj.2010.40.1.1 – volume: 17 start-page: 197 issue: 1 year: 2018 ident: 1839_CR49 publication-title: Lipids in Health and Disease doi: 10.1186/s12944-018-0828-z – volume: 20 start-page: 795 issue: 10 year: 2021 ident: 1839_CR2 publication-title: Lancet Neurology doi: 10.1016/S1474-4422(21)00252-0 – volume: 20 start-page: 201 issue: 1 year: 2021 ident: 1839_CR21 publication-title: Cardiovascular Diabetology doi: 10.1186/s12933-021-01393-5 – volume: 21 start-page: 137 issue: 1 year: 2022 ident: 1839_CR33 publication-title: Cardiovascular Diabetology doi: 10.1186/s12933-022-01570-0 – volume: 11 start-page: 966 issue: 7 year: 2023 ident: 1839_CR54 publication-title: Healthcare (Basel, Switzerland) – volume: 12 start-page: 679415 year: 2021 ident: 1839_CR44 publication-title: Frontiers in Neurology doi: 10.3389/fneur.2021.679415 – volume: 64 start-page: 2525 issue: 23 year: 2014 ident: 1839_CR18 publication-title: Journal of the American College of Cardiology doi: 10.1016/j.jacc.2014.09.042 – ident: 1839_CR32 doi: 10.1159/000343145 – volume: 38 start-page: 1253 issue: 8 year: 2022 ident: 1839_CR41 publication-title: Canadian Journal of Cardiology doi: 10.1016/j.cjca.2022.03.009 |
| SSID | ssj0017861 |
| Score | 2.5318775 |
| Snippet | Background
The atherogenic index of plasma (AIP) is an important alternative metabolic biomarker of atherosclerosis and cardiovascular diseases. Nevertheless,... The atherogenic index of plasma (AIP) is an important alternative metabolic biomarker of atherosclerosis and cardiovascular diseases. Nevertheless, the... BackgroundThe atherogenic index of plasma (AIP) is an important alternative metabolic biomarker of atherosclerosis and cardiovascular diseases. Nevertheless,... Abstract Background The atherogenic index of plasma (AIP) is an important alternative metabolic biomarker of atherosclerosis and cardiovascular diseases.... |
| SourceID | doaj pubmedcentral proquest pubmed crossref springer |
| SourceType | Open Website Open Access Repository Aggregation Database Index Database Enrichment Source Publisher |
| StartPage | 125 |
| SubjectTerms | Angiology Arteriosclerosis Atherogenic index of plasma Atherosclerosis Biomarkers Body mass index Cardiology Cardiovascular disease Cardiovascular diseases Carotid Artery Diseases - diagnostic imaging Carotid Artery Diseases - epidemiology Carotid atherosclerosis Carotid Intima-Media Thickness Carotid plaque China - epidemiology Cholesterol Cholesterol, HDL Cohort analysis Cohort Studies Comorbidity Diabetes High density lipoprotein Humans Inflammation and Cardiometabolic Disease Medicine Medicine & Public Health Plaque, Atherosclerotic Plaques Population studies Population-based studies Reclassification Regression analysis Retrospective Studies Risk assessment Risk Factors Stenosis Stroke Triglycerides Veins & arteries |
| SummonAdditionalLinks | – databaseName: DOAJ Directory of Open Access Journals dbid: DOA link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Jb9UwELZQD4gLAsoSKMhI3MBqEu_caEVVIZUTlXqzvKpPguSpLz28E3-dsbOUx3rpJVLisWV5vom_0dgzCL1xYD_KS0401Y4wbhuiU-SE106I1ICpl2z7Z5_F6Tn7dMEvfir1lc-EjemBx4U7FCloabWMTAnmAIHRA4iYFTVjrkku_31rXc_O1BQ_kEo08xUZJQ43eVfL8cp8dggoAdnubEMlW_-fKObvJyV_CZeWXejkAbo_0Uf8YZz2Q3Qndo_Q3bMpQL6PvoPacSF1PSBj5XHJhoj7hNdAk79ZbLuAc6meYRUmuQ0MBM_VBmSxxX68MTJs8Xqp7fUevt-8kbzzwSj9JVB3XPLT5q6lEvdjdH7y8cvxKZlqLBAvajWQEKlvZZC0baxwnAUpXa1tFMIpbSW3iTKafJTcca9a6T3zntrIg7WUhkCfoL2u7-IzhENI1LoUWpoalhxzyeegXStdjn0mV6FmXnLjpwTkuQ7GV1McESXMqCYDajJFTWZbobdLn_WYfuOf0kdZk4tkTp1dPgCgzAQo8z9AVehgxoGZ7HljwDGVtWiBW1fo9dIMlpjDK7aL_XWRyU4-kKoKPR1hs8yESqBRWvMKqR1A7Ux1t6VbXZZs39klB1YHg76bsXczr7-vxfPbWIsX6F5bjCbfWzxAe8PVdXwJJGxwr4q9_QC8YzBi priority: 102 providerName: Directory of Open Access Journals – databaseName: Health & Medical Collection dbid: 7X7 link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1Lb9QwELagSIgL4k2gICNxA6tJ_Eq4IEBUFVI5UWlvlp90pZIsTXrYE3-dseNktTx6iZR4bDmeGfsbjz2D0GsD-tNYyUlLW0MY1xVpg-eEl0aIUIGqp2j7p1_FyRn7suKrvOE25GOV85yYJmrX27hHfgSmgSwFmOrl-81PErNGRe9qTqFxE92qAInE1A1ytRhclWxENV-UacTRENe26LWMJ4gAGJDt3mKUYvb_C2j-fV7yD6dpWouO76G7GUTiDxPX76MbvnuAbp9mN_lD9AuYjxO060E-1hanmIi4D3gDYPmHxrpzOCbsGdcu0w3QEDzXA9Bije10b2Tc4s2S4esdfN-9kbj-QSv9OQB4nKLUxqopH_cjdHb8-dunE5IzLRArymYkzlNbSydpXWlhOHNSmrLVXgjTtFpyHSijwXrJDbfACGuZtVR77rSm1Dn6GB10feefIuxcoNoEV9NQsWCYCTa67mppogc0mAJV85Arm8OQx2wYFyqZI41QE5sUsEklNqltgd4sdTZTEI5rqT9GTi6UMYB2-tBffldZH5UIrpW6lZ41ghmY2LwFeWFalIyZKnbzcJYDlbV6UDsZLNCrpRj0MTpZdOf7q0QTTX2AVgV6MonN0hMqAUy1LS9QsydQe13dL-nW5ynmdzTMAdtBo29n2dv16_9j8ez633iO7tRJHeK9xEN0MF5e-RcAskbzMmnSb--OJ_4 priority: 102 providerName: ProQuest – databaseName: Springer Nature Open Access Journals dbid: C6C link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV3NaxUxEA9aQbyIrV-rrUTwpsHdzbc3fVhKoZ4s9BbySR_o7qNve3gn_3Un2X1bn1bBy8JuJiFkZnZ-YZLfIPTGgf8oLznRVDvCuG2ITpETXjshUgOuXtj2z76Ik3N2esEvJpqcfBfm1_x9o8T7dY5HOdOYT_1AMCebu-gehx9vtuaFWMwZA6lEs70Uc2u_ncBT-PlvA5V_no38LUFa4s7xI_RwAoz446jhfXQndgfo_tmUEn-MfoCicYFxPdjC0uPCf4j7hFcAjL9bbLuAc3GeYRkmuTUMBM_lGmSxxX68IzJs8Gqu5vUBvt-8kRzrYJT-EsA6Loy0uWupvf0EnR9__ro4IVNVBeJFrQYSIvWtDJK2jRWOsyClq7WNQjilreQ2UUaTj5I77lUrvWfeUxt5sJbSEOhTtNf1XXyOcAiJWpdCS1PDkmMu-Zyma6XL2c7kKtRsl9z4iXI8V774ZsrWQwkzqsmAmkxRk9lU6O3cZzUSbvxT-lPW5CyZybLLB7AhM_meESloabWMTAnm4CcWPdgLs6JmzDV5modbOzCTB68NbEVlLVpA0xV6PTeD7-WEiu1if11k8rYeYFSFno1mM8-ESgBOWvMKqR2D2pnqbku3vCz83nkTDjgOBn23tb2bef19LV78n_hL9KAt7pHvJB6iveHqOh4BwBrcq-JZPwGpQiGF priority: 102 providerName: Springer Nature |
| Title | The atherogenic index of plasma and carotid atherosclerosis in a community population: a population-based cohort study in China |
| URI | https://link.springer.com/article/10.1186/s12933-023-01839-y https://www.ncbi.nlm.nih.gov/pubmed/37244995 https://www.proquest.com/docview/2827062020 https://www.proquest.com/docview/2820027008 https://pubmed.ncbi.nlm.nih.gov/PMC10225098 https://doaj.org/article/6fd97a97e4864b318ec0174a6044b1fb |
| Volume | 22 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3db9MwED_tQ5r2gvimY1RG4g0CTezYCRJCXbVpqrQJAZX6FvlzqzSS0nbS-sS_ztlJWgqFB14SxTk7lu93ubPPvgN4pVB-Mi3SKKe5ilgq4yh3No3SnuLcxSjqIdr-xSU_H7HhOB3vQJvuqBnA-dapnc8nNZrdvL37vvyIAv8hCHzG3829zvLeSL8zCBV-tNyF_eAv8lv52NqrIDIetwdnttY7hAMqUOHlPt3EL3oqhPPfZoP-uZXyN39qUFNn9-FeY1-Sfg2IB7Bjy4dwcNF40B_BD8QFCVZfhdCZaBLCJZLKkSna0d8kkaUhPpfPYmIaujk2hNfJHGmJJLo-UrJYkukq-dd7LF8_RV41YivVNQ4rCQFsfdWQqvsxjM5Ovw7OoyYJQ6R5L1tExlKdCCNoEkuuUmaEUL1cWs5VlkuRSkcZddqKVKU6S4TWTGsqbWqkpNQY-gT2yqq0z4AY46hUziTUxcwpppz2XEqE8s5RpzoQt0Ne6CZCuU-UcVOEmUrGi5pjBXKsCBwrlh14vaozreNz_JP6xHNyRelja4eCanZVNKJacGdyIXNhWcaZwn-e1QgdJnmPMRX7bh63OChavBY4cxU9nqDx3YGXq9coqt7_Iktb3QYavwqAVlcHntawWfWkhV0Hsg1AbXR18005uQ7hwP2cHc0-bPRNi711v_4-Fkf__6XncJgEqfHHGY9hbzG7tS_QNluoLuyKsejCfr8__DLE-8np5afPWDrgg25Y7-gGkfwJeVw-9A |
| linkProvider | Scholars Portal |
| linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtR3LbtNAcFVSCbgg3gQKLBKcwKrtfdlIFaLQKqVNhFAr9bbss41U7NCkQjnxZ3wbsxvbUXj01osl2-PVeOexMzs7Mwi91CA_hREsKUmpE8pUlpTesYSlmnOfgajHavvDER8c0U_H7HgN_WpzYcKxylYnRkVtaxP2yDfBNRApB1c9fTf5noSuUSG62rbQUE1rBbsVS4w1iR37bv4DXLjp1t5HoPerPN_dOfwwSJouA4nhaTFLrCMmF1aQPFNcM2qF0GmpHOe6KJVgyhNKvHGCaWYACWOoMUQ5ZpUixFoC415D6zRsoPTQ-vbO6POXLo4hCp61qToF35yG1TXETcMZJjBNkvnKchi7BvzL1P37xOYfYdu4Gu7eRrcaMxa_X_DdHbTmqrvo-rAJ1N9DP4H9cDQua-DQscGxKiOuPZ6Auf5NYVVZHFoGwWQ2cFMYCK7jKcBihc0ic2U2x5Oux9hbeL68S8IKDKPUp-BC4FgnN3waO4LfR0dXQoUHqFfVlXuEsLWeKO1tTnxGvabamxA8zIUOMViv-yhrp1yaphB66MdxJqNDVHC5IJMEMslIJjnvo9fdN5NFGZBLobcDJTvIUMI7PqjPT2SjEST3thSqFI4WnGpQrc4Av1DFU0p1FtDcaPlANnplKpdS0EcvutegEUKYR1WuvogwYbMBjLs-erhgmw4TIsCcK0vWR8UKQ62guvqmGp_GquNhawCsSxj0Tct7S7z-PxePL_-N5-jG4HB4IA_2RvtP0M08ikbIktxAvdn5hXsKJt9MP2vkCqOvVy3KvwHFX21- |
| linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1Lb9QwELaglSouiDdpCxiJG0TdxK-Y2_JYlYVWSFCpN8vPdiVIVt30sCf-OmPnURYKEpdIiceW5ZnJfKPxzCD0woD-VFawXBJpcsp0kcvgWc4mhvNQgKqnavtHx_zwhM5P2ekvWfzptvsQkuxyGmKVpro9WLrQqXjFD1bRSsX4Y7wLBCY-X99E2xWTEtyv7el0_mU-RhJExYshWebamRsGKdXtvw5s_nln8rfAabJHszvodg8k8bTj_F10w9f30M5RHyq_j36AAOAE7xqQkYXFqS4ibgJeAmD-rrGuHY5Ne9qF6-lWsBA8FyugxRrbLnekXePl2OXrNXy_esujDYRVmnMA8ThVqo1TU0_uB-hk9v7r28O877aQWz6p2tx5YkvhBCkLzQ2jTggzkdpzbiqpBdOBUBKsF8wwW5XCWmot0Z45rQlxjjxEW3VT-8cIOxeINsGVJBQ0GGqCjeG7UpgYBQ0mQ8Vw5Mr2pchjR4xvKrkkFVcdmxSwSSU2qXWGXo5zll0hjn9Sv4mcHCljEe30obk4U71OKh6cFFoKTytODfzcvAV5oZpPKDVF3Ob-IAeq1-yVAhdVTHgJKDtDz8dh0MkYaNG1by4TTXT3AV5l6FEnNuNOiABAJSXLULUhUBtb3RypF-ep7nd0zgHfwaKvBtm72tffz2L3_8ifoZ3P72bq04fjj3voVpk0JaYt7qOt9uLSPwEM1pqnvZr9BDbuLjI |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=The+atherogenic+index+of+plasma+and+carotid+atherosclerosis+in+a+community+population%3A+a+population-based+cohort+study+in+China&rft.jtitle=Cardiovascular+diabetology&rft.au=Huang%2C+Qin&rft.au=Liu%2C+Zeyu&rft.au=Wei%2C+Minping&rft.au=Huang%2C+Qing&rft.date=2023-05-27&rft.pub=BioMed+Central&rft.eissn=1475-2840&rft.volume=22&rft_id=info:doi/10.1186%2Fs12933-023-01839-y&rft_id=info%3Apmid%2F37244995&rft.externalDocID=PMC10225098 |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1475-2840&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1475-2840&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1475-2840&client=summon |